QCI.png
Andrew Cardno Leads a Seminar at IGA: Unraveling the Impact of Recent Cyber Attacks on Indian Gaming
March 27, 2024 14:26 ET | QCI
SAN DIEGO, March 27, 2024 (GLOBE NEWSWIRE) -- The 2024 Indian Gaming Tradeshow and Convention in Anaheim, California, is set to host a pivotal session on the pressing issue of cyber security within...
AEG Horiz_RGB_REG_tag.jpg
Aegion Announces Acquisition of Toncco
March 27, 2024 11:00 ET | Aegion Corp
Aegion Corporation today announced the acquisition of Toncco, an underground utilities company based in Ogden, Utah.
22157.jpg
Global Animal and Pet Food Market Analysis 2018-2023 and Forecast 2024-2033 Featuring Profiles of Cargill, Nestle, New Hope Liuhe Co, Charoen Pokphand Foods, and Bunge
March 27, 2024 08:10 ET | Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Animal And Pet Food Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The animal and pet food market has grown...
AECON_Red.jpg
Aecon consortium selected to redevelop the Cyril E. King Airport and Henry E. Rohlsen Airport in the U.S. Virgin Islands
March 26, 2024 17:46 ET | Aecon Group Inc.
TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- Aecon Group Inc. (TSX: ARE) (“Aecon”) announced today that VIports Partners (“VIports”), an Aecon-led consortium, has been selected by the U.S. Virgin...
GENE logo.png
GTG Global Collaborations and Innovation Update
March 26, 2024 08:00 ET | Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
Christy Bray Ricks
PracticeLink Announces Appointment of Christy Bray Ricks as Chief Strategic Officer
March 25, 2024 12:45 ET | PracticeLink
ST. LOUIS and HINTON, West Virginia, March 25, 2024 (GLOBE NEWSWIRE) -- AAPPR -- PracticeLink, the nation’s most trusted physician recruitment resource and home of the most widely used online...
Full Logo - OKYO .jpg
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief in its First-in-Human Phase 2 Trial of OK-101
March 22, 2024 07:00 ET | OKYO Pharma LTD
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Initiates Registration Stage of the ESLIM-02 Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China
March 21, 2024 20:00 ET | HUTCHMED (China) Limited
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., March 22, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the...
Full Logo - OKYO .jpg
OKYO Pharma to Host Key Opinion Leader Event to Discuss New and Comprehensive Data from Phase 2 Dry Eye Disease Trial
March 21, 2024 07:00 ET | OKYO Pharma LTD
-Phase 2 OK-101 efficacy data to be released March 22nd, 2024- -KOL Event to be held on April 9th, 2024 at 12 PM ET- LONDON and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited...
QCI.png
Brian Parrish COO of Osage Nation Announces Eye Opening Results from QCI College
March 20, 2024 15:18 ET | QCI
SAN DIEGO, March 20, 2024 (GLOBE NEWSWIRE) -- As more companies are leveraging the powerful capabilities of the QCI Enterprise Platform, QCI proudly introduces QCI College – a unique initiative that...